Literature DB >> 7379385

The operative treatment of Achilles tendon injuries.

D W Lennox, G J Wang, F C McCue, W G Stamp.   

Abstract

Twenty cases of Achilles tendon injury treated surgically at the University of Virginia Medical Center from 1970 to 1979 were reviewed and reevaluated with up to 9 years of follow-up. Three treatment groups were identified: Group I--primary repair of a lacerated Achilles tendon; Group II--primary repair of an acutely ruptured Achilles tendon; and Group III--subacute repair of Achilles tendon rupture (performed more than 72 hours after injury). Acute repairs were performed by end-to-end suture. In subacute cases the anastomosis was reinforced with one or 2 flaps from the gastrocnemius tendon. Strenuous exercise accounted for nearly all the cases of acute tendon rupture. Surgical complications and overall functional results were determined for each treatment group. Open repair provides excellent results when applied to lacerations. A good-to-excellent overall result can be expected for patients with acute ruptures and primary repair, but an awareness of the possible postoperative complications is necessary. Achilles tendon ruptures that go unrecognized for more than 72 hours are best treated conservatively.

Entities:  

Mesh:

Year:  1980        PMID: 7379385

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  4 in total

1.  Calf pain in athletes.

Authors:  N E Vincent; W D Stanish
Journal:  Can Fam Physician       Date:  1989-08       Impact factor: 3.275

2.  EXPERIENCE WITH MANAGING OPEN ACHILLES TENDON INJURIES IN A TERTIARY HOSPITAL IN SOUTHERN NIGERIA.

Authors:  A A Awe; E E Esezobor; Q O Aigbonoga
Journal:  J West Afr Coll Surg       Date:  2015 Oct-Dec

3.  Tendo Achillis pain: steroids and outcome.

Authors:  M T Read; S G Motto
Journal:  Br J Sports Med       Date:  1992-03       Impact factor: 13.800

Review 4.  Achilles tendon lesions in sport.

Authors:  J G Williams
Journal:  Sports Med       Date:  1986 Mar-Apr       Impact factor: 11.136

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.